Cardiac Imaging in Taiwan: A Far Eastern Memorial Hospital study of 1,007 patients suggests the key predictor of serious heart events isn’t just what heart scans look like, but the absolute numbers from myocardial blood flow and flow reserve—potentially improving risk forecasting over ~4 years. TB Screening for Psoriasis: A new debate piece highlights how psoriasis patients starting IL-23 inhibitors face inconsistent guidance on whether they need baseline TB testing and repeat testing, pointing to gaps between older TNF-based protocols and today’s drug mechanisms. Cancer Drug Update: Daiichi Sankyo and Merck (MSD) voluntarily withdrew a U.S. accelerated-approval application for ifinatamab deruxtecan in extensive-stage small cell lung cancer after FDA discussions found the data didn’t meet requirements; a phase 3 trial continues. Taiwan Expo USA 2026 (Health Tech): Taiwan Excellence’s “Galaxy Amusement Park” at the Dallas expo showcased AI and healthcare innovations, aiming to turn U.S. interest into partnerships. Flu Vaccines: Taiwan plans to roll out flu vaccines Oct. 1 as the epidemic persists. Diabetes Safety Signal: A report links brief corticosteroid use to serious adverse events in type 2 diabetes, adding pressure on careful prescribing.